Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Ecaterina E Ileana, Dumbrava"'
Autor:
Heather Lin, Vivek Subbiah, Siqing Fu, Aung Naing, Courtney Nicholas, Shubham Pant, Chad Tang, Michael A Curran, David S Hong, Ying Yuan, Sarina A Piha-Paul, Jordi Rodon Ahnert, Timonthy A Yap, Apostolia M Tsimberidou, Daniel D Karp, Anupallavi Srinivasamani, Coline Couillault, Genevieve P Hartley, James Dai, Ecaterina E Ileana Dumbrava, Paola Guerrero, Sarah Dhebat, Theresa Proia
Publikováno v:
BMJ Oncology, Vol 3, Iss 1 (2024)
Objective To evaluate signal transducer and activator of transcription 3 (STAT3) inhibition we conducted a co-clinical trial testing danvatirsen, a STAT3 antisense oligonucleotide (ASO) and checkpoint inhibition in conjunction with preclinical experi
Externí odkaz:
https://doaj.org/article/fd1c2105b438497dab4139b2a44f11d7
Autor:
Carol J. Nowlen, Molly Daniels, Burak Uzunparmak, Ecaterina E. Ileana Dumbrava, Ying Yuan, Keyur P. Patel, Nadine Rayes, Jacqueline Harkenrider, Chetna Wathoo, Jennifer Veazie, Krystle A. Luna, Wanlin Wang, Chacha Horombe, Milind Javle, Jordi Rodon Ahnert, Timothy A. Yap, Banu Arun, Karen H. Lu, Funda Meric-Bernstam
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Vol 7, Iss 1, Pp 7-17 (2024)
Introduction Genomic profiling is performed in patients with advanced or metastatic cancer, in order to direct cancer treatment, often sequencing tumor-only, without a matched germline comparator. However, because many of the genes analyzed on tumor
Externí odkaz:
https://doaj.org/article/1c82c80e6fbe4a119579d33a7fda0372
Autor:
Shuyang Yao, Funda Meric-Bernstam, David Hong, Filip Janku, Aung Naing, Sarina Anne Piha-Paul, Apostolia Maria Tsimberidou, Daniel Karp, Vivek Subbiah, Timothy Anthony Yap, Jordi Rodon Ahnert, Shubham Pant, Ecaterina E Ileana Dumbrava, Chetna Wathoo, Erick Campbell, Lihou Yu, Yuko Yamamura, Siqing Fu
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Cyclin E is frequently encoded by CCNE1 gene amplification in various malignancies. We reviewed the medical records of patients with solid tumors displaying CCNE1 amplification to determine the effect of this amplification for future therape
Externí odkaz:
https://doaj.org/article/a5b386ae4dfe4117b0a471663d796ae6
Autor:
Vivek Subbiah, Linghua Wang, Sara Ahmed, Michael Frumovitz, Jing Gong, Chantale Bernatchez, Siqing Fu, Aung Naing, Funda Meric-Bernstam, Shubham Pant, Nizar Tannir, Renata Ferrarotto, Joud Hajjar, Shi-Ming Tu, Mingxuan Xu, Anas Alshawa, Bettzy Stephen, Matthew Campbell, David S Hong, Sarina A Piha-Paul, Jordi Rodon Ahnert, Apostolia M Tsimberidou, Daniel D Karp, Timothy A Yap, Rivka R Colen, Vinod Ravi, Camilo Jimenez, Kanwal P Raghav, Gauri R Varadhachary, Ecaterina E Ileana Dumbrava, Sarjeel H Sabir, Saria Khan, Jeane M Painter, Abulrahman Abonofal, Richard M Simon
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background Patients with advanced rare cancers have poor prognosis and few treatment options. As immunotherapy is effective across multiple cancer types, we aimed to assess pembrolizumab (programmed cell death 1 (PD-1) inhibitor) in patients with adv
Externí odkaz:
https://doaj.org/article/633cee93179a43e799cae34404daa006
Autor:
Funda Meric-Bernstam, Gordon B. Mills, Elmer V. Bernstam, Kenna Mills Shaw, John Mendelsohn, Vijaykumar Holla, Nora S. Sánchez, Ann M. Bailey, Md Abu Shufean, Jia Zeng, Jordi Rodon, Timothy A. Yap, Amber M. Johnson, Yekaterina B. Khotskaya, Beate Litzenburger, Ecaterina E. Ileana Dumbrava, Katherine C. Kurnit
Terminology definitions as used by the Precision Oncology Decision Support (PODS) team at MD Anderson Cancer Center
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b8156b415ff44b634ccdef64fd80917
https://doi.org/10.1158/1078-0432.22464254
https://doi.org/10.1158/1078-0432.22464254
Autor:
Funda Meric-Bernstam, Gordon B. Mills, Elmer V. Bernstam, Kenna Mills Shaw, John Mendelsohn, Vijaykumar Holla, Nora S. Sánchez, Ann M. Bailey, Md Abu Shufean, Jia Zeng, Jordi Rodon, Timothy A. Yap, Amber M. Johnson, Yekaterina B. Khotskaya, Beate Litzenburger, Ecaterina E. Ileana Dumbrava, Katherine C. Kurnit
Prominent commercial vendors providing decision support services (as of November 1, 2017)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2701ce634cc7531c6fd06fd0675e22be
https://doi.org/10.1158/1078-0432.22464251
https://doi.org/10.1158/1078-0432.22464251
Autor:
Sarina A. Piha-Paul, Jordi Rodon, Rashmi K. Murthy, Michelle Bhatt, Kavitha Balaji, Kanwal Raghav, Ecaterina E. Ileana Dumbrava, Amber M. Johnson, Funda Meric-Bernstam
Supplementary Table S1. FDA approved HER2-targeted therapies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::900760de285861abc2ddbd13ac085dc1
https://doi.org/10.1158/1078-0432.22472924.v1
https://doi.org/10.1158/1078-0432.22472924.v1
Autor:
Funda Meric-Bernstam, Gordon B. Mills, Elmer V. Bernstam, Kenna Mills Shaw, John Mendelsohn, Vijaykumar Holla, Nora S. Sánchez, Ann M. Bailey, Md Abu Shufean, Jia Zeng, Jordi Rodon, Timothy A. Yap, Amber M. Johnson, Yekaterina B. Khotskaya, Beate Litzenburger, Ecaterina E. Ileana Dumbrava, Katherine C. Kurnit
With the increasing availability of genomics, routine analysis of advanced cancers is now feasible. Treatment selection is frequently guided by the molecular characteristics of a patient's tumor, and an increasing number of trials are genomically sel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::405ec5773362f612feaae9102c9af871
https://doi.org/10.1158/1078-0432.c.6525656
https://doi.org/10.1158/1078-0432.c.6525656
Autor:
Funda Meric-Bernstam, Gordon B. Mills, Elmer V. Bernstam, Kenna Mills Shaw, John Mendelsohn, Vijaykumar Holla, Nora S. Sánchez, Ann M. Bailey, Md Abu Shufean, Jia Zeng, Jordi Rodon, Timothy A. Yap, Amber M. Johnson, Yekaterina B. Khotskaya, Beate Litzenburger, Ecaterina E. Ileana Dumbrava, Katherine C. Kurnit
Actionable gene list for the Precision Oncology Decision Support (PODS) team at MD Anderson Cancer Center (as of November 1, 2017)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::097c09fca795e4820b817bddc1168db6
https://doi.org/10.1158/1078-0432.22464248.v1
https://doi.org/10.1158/1078-0432.22464248.v1
Autor:
Shuyang Yao, Funda Meric-Bernstam, David Hong, Filip Janku, Aung Naing, Sarina Anne Piha-Paul, Apostolia Maria Tsimberidou, Daniel Karp, Vivek Subbiah, Timothy Anthony Yap, Jordi Rodon Ahnert, Shubham Pant, Ecaterina E Ileana Dumbrava, Chetna Wathoo, Erick Campbell, Lihou Yu, Yuko Yamamura, Siqing Fu
Publikováno v:
Scientific reports. 12(1)
Cyclin E is frequently encoded by CCNE1 gene amplification in various malignancies. We reviewed the medical records of patients with solid tumors displaying CCNE1 amplification to determine the effect of this amplification for future therapeutic deve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::044f834bbce4a3136b7444d4a47af669
https://pubmed.ncbi.nlm.nih.gov/35610322
https://pubmed.ncbi.nlm.nih.gov/35610322